1.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
|
|
2.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897
|
|
3.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: SJCRH-ALL-TT-8
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: DFCI-77001, NCI-T83-1310D, T83-1310
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-81001, NCI-D82-018-0400, D82-018-0400
|
|
7.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: POG-8698
|
|
8.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 20
Sponsor:
Protocol IDs: ARG-GATLA-3LMA83
|
|
9.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-8862
|
|
10.
|
Phase: Phase III, Phase I
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: DFCI-76006, DFCI-VAPA-10
|
|
11.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9406, POG-ALINC-16/HR
|
|
12.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 through 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9405, POG-ALINC-16/SR
|
|
13.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 22
Sponsor: NCI
Protocol IDs: POG-9315, NCT00002618
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 60
Sponsor: Other
Protocol IDs: CDR0000064498, EORTC-06951, FRE-LALA-94, NCT00002700
|
|
15.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 74
Sponsor:
Protocol IDs: EORTC-06952, ITA-GIMEMA-AIEOP-1, NCT00002701
|
|
16.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9605
|
|
17.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 0 to 21
Sponsor: NCI, Other
Protocol IDs: CDR0000064664, POG-9404, NCT01230983
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI
Protocol IDs: CCG-1952, NCT00002744
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 1 and under 15
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-XI, EU-95036
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MSKCC-96015A1, NCI-V96-0881, NCT00002766
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: CCG-1961, NCT00002812
|
|
23.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to 17
Sponsor: NCI, Other
Protocol IDs: CDR0000066202, DFCI-95001, DFCI-FDR001197, NCI-G99-1651, NCT00004034
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 15
Sponsor:
Protocol IDs: UKCCSG-NHL-9503, EU-98012, NCT00003423
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to 18
Sponsor: Other
Protocol IDs: MRC-LEUK-ALL97, EU-97032, NCT00003437
|
Mobile | Español
